APOL1 and infection: In vitro studies have shown that APOL1-G2 exhibits almost no binding to SRA (Thomson et al., 2014); therefore, APOL1-G2 can render the parasite inactive, ensuring that humans remain safeguarded against infection (Beckerman and Susztak, 2018; Cooper et al., 2017).